Maerkl, F; Schultheiss, C; Ali, M; Chen, SS; Zintchenko, M; Egli, L; Mietz, J; Chijioke, O; Paschold, L; Spajic, S; Holtermann, A; Doerr, J; Stock, S; Zingg, A; Laeubli, H; Piseddu, I; Anz, D; Minden, MDV; Zhang, TJ; Nerreter, T; Hudecek, M; Minguet, S; Chiorazzi, N; Kobold, S; Binder, M. (2024) Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia